Upfront DPYD genotyping and toxicity associated with fluoropyrimidine-based concurrent chemoradiotherapy for oropharyngeal carcinomas.

Antoine Désilets,Francine Aubin,Houda Bahig,Olivier Ballivy,Danielle Charpentier,Edith Filion,Rahima Jamal,Louise Lambert,Charles Vadnais,Xiaoduan Weng,Denis Soulières

Upfront DPYD genotyping and toxicity associated with fluoropyrimidine-based concurrent chemoradiotherapy for oropharyngeal carcinomas.

2020

Antoine Désilets
Francine Aubin
Houda Bahig
Olivier Ballivy
Danielle Charpentier
Edith Filion
Rahima Jamal
Louise Lambert
Charles Vadnais
Xiaoduan Weng
Denis Soulières

6580Background: The combination of carboplatin and 5-fluorouracil (5-FU) is effective when used concurrently with radiotherapy for locoregionally advanced oropharyngeal carcinomas (Calais et al. 19...

Keywords:

concurrent chemoradiotherapy
DPYD
Oncology
Internal medicine
Toxicity
Medicine
Genotyping
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations